$88.53 +6.19 (%) Heartware International Inc - NASDAQ

Jul. 30, 2015 | 11:59 AM

Partner Headlines

  1. New Cardiac Devices Get Investors' Hearts Pumping

    IBD | Jul. 24, 2015 | 15:16PM EST
  2. St. Jude Medical Nabs Thoratec, Beats Q2 Estimates

    IBD | Jul. 22, 2015 | 10:28AM EST
  3. Contemporary Results From Commercial HVAD System Registries Highlighted At ISHLT Meeting

    Benzinga | Apr. 20, 2015 | 16:33PM EST
  4. Credit Suisse: Keep An Eye On These 6 Healthcare Stocks In 2015

    Benzinga | Jan. 11, 2015 | 12:59PM EST
  5. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 11:04AM EST
  6. Baron Funds Comments on HeartWare International

    GuruFocus | May. 5, 2014 | 18:27PM EST
  7. Benzinga's Top Downgrades

    Benzinga | Apr. 14, 2014 | 08:41AM EST
  8. HEARTWARE

    IBD | Jan. 14, 2014 | 18:46PM EST
  9. From HeartWare Presentation at JP Morgan Healthcare Conference: Co. Had Unaudited Q4 Sales of $53M

    Benzinga | Jan. 14, 2014 | 16:39PM EST
  10. ETF Outlook for Tuesday, December 17: (PEJ, IHI, DIA, CARZ, SBUX)

    Benzinga | Dec. 17, 2013 | 10:39AM EST
  11. HeartWare Acquires CircuLite for $30M in Cash, Stock Deal

    Benzinga | Dec. 1, 2013 | 22:44PM EST
  12. HeartWare Wins FDA Approval to Enroll Supplemental Patient Cohort in Destination Therapy Trial

    Benzinga | Aug. 27, 2013 | 09:12AM EST
  13. UPDATE: Credit Suisse Upgrades HeartWare Following 2Q Results Report

    Benzinga | Aug. 9, 2013 | 11:05AM EST
  14. HeartWare Sees Q4 Sales ~$32M

    Benzinga | Jan. 7, 2013 | 06:45AM EST
  15. UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT on HeartWare International

    Benzinga | Dec. 3, 2012 | 02:25AM EST
  16. Stocks Hold Modest Gains; Stratasys Breaks Out

    IBD | Nov. 21, 2012 | 06:42AM EST
  17. UPDATE: Wedbush Securities Raises PT to $105 on HeartWare International as FDA Approves HVAD

    Benzinga | Nov. 21, 2012 | 06:37AM EST
  18. Earnings Scheduled For November 9, 2012

    Benzinga | Nov. 8, 2012 | 18:58PM EST
  19. UPDATE: Wunderlich Reiterates Hold Rating, Raises PT on HeartWare International

    Benzinga | Aug. 8, 2012 | 07:24AM EST
  20. UPDATE: Piper Jaffray Raises PT on HeartWare International from $88 to $93

    Benzinga | Aug. 8, 2012 | 03:39AM EST
  21. UPDATE: Wedbush Increases Fair Value Estimate on HeartWare International from $98 to $101

    Benzinga | Aug. 8, 2012 | 03:37AM EST
  22. UPDATE: Goldman Sachs Initiates HeartWare International with Neutral

    Benzinga | Jul. 13, 2012 | 07:28AM EST
  23. UPDATE: Piper Jaffray Raises PT to $88 on HeartWare International on Positive Sector Sentiment

    Benzinga | Jul. 3, 2012 | 01:51AM EST
  24. Oppenheimer Reiterates Perform Rating, Does Not Set PT for HeartWare

    Benzinga | May. 11, 2012 | 13:05PM EST
  25. UPDATE: Piper Jaffray Maintains Neutral Rating, Raises PT for HeartWare International

    Benzinga | May. 11, 2012 | 04:38AM EST
  26. UPDATE: Canaccord Genuity Raises HeartWare International's PT

    Benzinga | May. 11, 2012 | 03:21AM EST
  27. Heartware Sees Q4 Revenue of $22M vs $24.5M Est

    Benzinga | Jan. 9, 2012 | 07:24AM EST
  28. Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 10,462 Shares

    GuruFocus | Dec. 21, 2011 | 12:37PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!